✦ LIBER ✦

18F-florbetaben Aβ imaging in mild cognitive impairment

✍ Scribed by Kevin Ong, Victor L Villemagne, Alex Bahar-Fuchs…

Book ID: 120715746
Publisher: BioMed Central
Year: 2013
Tongue: English
Weight: 430 KB
Volume: 5
Category: Article
ISSN: 1758-9193
DOI: 10.1186/alzrt158

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Assessment of Aβ Deposition in Mild Cogn

Assessment of Aβ Deposition in Mild Cognitive Impairment with 18F-Florbetaben

✍ Kevin Ong; Victor L. Villemagne; Narelle Langdon; Gerhard Holl; Cornelia Reining 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 174 KB

Conversion from mild cognitive impairmen

Conversion from mild cognitive impairment to Alzheimer's disease over 12 months: Predictive value of Aβ imaging with 18F-Florbetaben

✍ Kevin Ong; Victor Villemagne; Alex Bahar-Fuchs; Fiona Lamb; Gael Chetelat; Corne 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Conversion from mild cognitive impairmen

Conversion from mild cognitive impairment to Alzheimer's disease over 12 months: Predictive value of Aβ imaging with 18F-Florbetaben

✍ Kevin Ong; Victor Villemagne; Alex Bahar-Fuchs; Fiona Lamb; Gael Chetelat; Gerha 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 58 KB

[11C]PIB, [18F]FDG and MR imaging in pat

[11C]PIB, [18F]FDG and MR imaging in patients with mild cognitive impairment

✍ A. Brück, J. R. Virta, J. Koivunen… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 184 KB

18F-flutemetamol amyloid imaging in Alzh

18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial

✍ Rik Vandenberghe; Koen Van Laere; Adrian Ivanoiu; Eric Salmon; Christine Bastin; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB 👁 2 views

Amyloid imaging in mild cognitive impair

Amyloid imaging in mild cognitive impairment subtypes

✍ David A. Wolk; Julie C. Price; Judy A. Saxton; Beth E. Snitz; Jeffrey A. James; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 542 KB

## Abstract ## Objective We utilized the amyloid imaging ligand Pittsburgh Compound B (PiB) to determine the presence of Alzheimer's disease (AD) pathology in different mild cognitive impairment (MCI) subtypes and to relate increased PiB binding to other markers of early AD and longitudinal outcom